Press Coverage

FDA Grants New Indication to Sleep-Disorder Drug Xywav

Article on new indication for drug to treat idiopathic hypersomnia in adults mentions potential for abuse highlighted in ISMP’s QuarterWatch report.

For the full text, visit Managed Healthcare Executive online.

More News